Trial intelligence / Profile preview

IV Ketorolac for Pain in Adolescent IUD Placement

NCT05875571Phase 4Recruiting

Sponsor
Arkansas Children’s Research Institute
Start
Feb 2024
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postprocedural pain (CPSP) comparing Ketorolac with Placebo (2 arms). Primary endpoint: Post procedural pain after IUD placement at 24 hours. Started Feb 2024; status: recruiting.

02

Drugs

ketorolac
03

Conditions

postprocedural pain (CPSP)

Beyond the preview

Go deeper on NCT05875571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05875571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call